Purdue Was Urged To Pay $14,000 Rebates Per Patient Hurt By Opioids, Documents Show
The suggestion was contained in a proposal made three years ago by McKinsey consultants, STAT reports.
Stat:
Purdue Was Advised To Pay Rebates To Insurers For Each Overdose
As Purdue Pharma faced serious challenges to OxyContin sales, the company was advised to consider paying rebates of up to $14,000 to health insurers for each patient who was harmed by its opioid painkiller in order to maintain those crucial business relationships, according to court documents. (Silverman, 11/19)
In other news —
Crain's New York Business:
Newer Drugs Improve Health Outcomes, Lower Care Costs: NYC Study
Prescription drug costs have skyrocketed in the U.S. in recent years. But research from Columbia Business School in Morningside Heights found that access to newer medications increases patients' likelihood of taking them, improving health outcomes and decreasing care costs. The research, which was announced this week, from Frank Lichtenberg, professor of healthcare management, found that patients are 2.5% more likely to start and stay on a course of treatment for every 10-year decrease in a drug's time on the market. That's equivalent to a $0.35 reduction in copayment for each day of a patient's therapy. (Henderson, 11/19)
Stat:
A Leading AI Researcher Calls For Standards To Ensure Equity And Fairness
A top researcher at the Massachusetts Institute of Technology on Thursday said that artificial intelligence systems developed for medicine must be more transparent and judged against a set of common standards to ensure fairness and equity. (Ross, 11/19)
